Related Experiment Video
Updated: Jun 2, 2025

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
Warfarin-induced gastrointestinal bleeding with acute liver failure: A case report
Jiahao Chen1, Le Li, Shiyu Wang
1Department of Pharmacy, The People's Hospital of Hezhou, Hezhou, China.
Warfarin-induced gastrointestinal bleeding and liver injury are rare but serious. Promptly stopping warfarin, adjusting the international normalized ratio (INR), and using liver support therapy can prevent liver failure.
Area of Science:
- Pharmacology
- Hepatology
- Gastroenterology
Background:
- Warfarin is a common anticoagulant for mechanical valve replacement.
- Acute liver damage from warfarin is rare but can be severe.
- This case highlights warfarin-induced gastrointestinal bleeding and liver injury.
Purpose of the Study:
- To report a rare case of warfarin-induced gastrointestinal bleeding with liver injury.
- To describe the management and therapy for this condition.
- To emphasize the importance of monitoring and intervention.
Main Methods:
- A 64-year-old woman with a mechanical mitral valve replacement presented with gastrointestinal bleeding and elevated INR.
- The patient developed acute liver injury.
- Treatment involved discontinuing warfarin, artificial liver support, and anti-inflammatory liver therapy.
Main Results:
- Liver enzymes and hyperbilirubinemia improved with treatment.
- Warfarin was restarted at a lower dose, with INR reaching 2.03.
- The patient was discharged on day 24 with no significant increase in liver enzymes.
Conclusions:
- Close monitoring of warfarin therapy and international normalized ratio (INR) is crucial.
- Prompt discontinuation of warfarin and appropriate liver support therapy can prevent warfarin-induced liver failure.
- Avoiding drug-drug interactions is essential in patients on warfarin.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Esophageal Varices-I: Introduction
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

